Key result
No wild poliovirus cases have been detected in Nigeria since October 2016, though multiple outbreaks of circulating vaccine-derived poliovirus type 2 have emerged since 2018.
Why the study?
Despite the absence of detected wild poliovirus cases since October 2016, ongoing insurgency left children unreached, and circulating vaccine-derived poliovirus type 2 emerged and spread.
Observational
While wild poliovirus transmission may have been interrupted in Nigeria, ongoing outbreaks of circulating vaccine-derived poliovirus type 2 require improved vaccination campaign quality and access to insurgent-held areas.
Answers are grounded in this paper and cite their sources.
Supports wild poliovirus interruption in Nigeria; leaves open optimal strategies for cVDPV2 outbreak control.
The number of wild poliovirus (WPV) cases in Nigeria decreased from 1,122 in 2006 to six WPV type 1 (WPV1) in 2014 (1). During August 2014-July 2016, no WPV cases were detected; during August-September 2016, four cases were reported in Borno State. An insurgency in northeastern Nigeria had resulted in 468,800 children aged <5 years deprived of health services in Borno by 2016. Military activities in mid-2016 freed isolated families to travel to camps, where the four WPV1 cases were detected. Oral poliovirus vaccine (OPV) campaigns were intensified during August 2016-December 2017; since October 2016, no WPV has been detected (2). Vaccination activities in insurgent-held areas are conducted by security forces; however, 60,000 unvaccinated children remain in unreached settlements. Since 2018, circulating vaccine-derived poliovirus type 2 (cVDPV2) has emerged and spread from Nigeria to Niger and Cameroon; outbreak responses to date have not interrupted transmission. This report describes progress in Nigeria polio eradication activities during January 2018-May 2019 and updates the previous report (2). Interruption of cVDPV2 transmission in Nigeria will need increased efforts to improve campaign quality and include insurgent-held areas. Progress in surveillance and immunization activities will continue to be reviewed, potentially allowing certification of interruption of WPV transmission in Africa in 2020.
No takes yet. Share an insight, caveat, or question.
Adamu et al. (2019) conducted an observational in Poliomyelitis. Oral poliovirus vaccine (OPV) campaigns was evaluated on Number of wild poliovirus (WPV) and circulating vaccine-derived poliovirus type 2 (cVDPV2) cases. No wild poliovirus cases have been detected in Nigeria since October 2016, though multiple outbreaks of circulating vaccine-derived poliovirus type 2 have emerged since 2018.
Synapse has enriched 10 related papers. Consider them for comparative context: